NASDAQ:LPDX

(LPDX) (LPDX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LPDX stock logo

About (LPDX) Stock (NASDAQ:LPDX)

LipoScience, Inc. is a vitro diagnostic company. The Company’s diagnostic test, the nuclear magnetic resonance (NMR) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. The Company’s Vantera system is the Company's automated clinical analyzer. As of January 25, 2013, over eight million NMR LipoProfile tests were ordered. The Vantera system is its automated clinical analyzer. In August 2012, the Company received Food and Drug Administration (FDA) clearance to market the Vantera system commercially to laboratories.

LPDX Stock News Headlines

Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
LPDX Historical Data
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
See More Headlines
Receive LPDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (LPDX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2014
Today
5/03/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:LPDX
CUSIP
53630M10
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

LPDX Stock Analysis - Frequently Asked Questions

How were (LPDX)'s earnings last quarter?

(LPDX) (NASDAQ:LPDX) announced its earnings results on Wednesday, November, 12th. The biotechnology company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.26) by $0.02. The biotechnology company had revenue of $8.56 million for the quarter, compared to analyst estimates of $8.80 million. During the same period last year, the business earned ($0.31) EPS.

What other stocks do shareholders of (LPDX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (LPDX) investors own include Altaba (AABA), Global Sources Ltd. Bermuda (GSOL), Alcoa (AA), Agios Pharmaceuticals (AGIO), AerCap (AER), AEGR (AEGR), Aegon (AEG) and Acorda Therapeutics (ACOR).

This page (NASDAQ:LPDX) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners